Company profile EFTR
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. eFFECTOR Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 16 |
| 2019 | 9 -43.8% QoQ | 85 844.4% QoQ | 8 -90.6% QoQ | 24 50.0% YoY 200.0% QoQ |
| 2020 | 78 766.7% YoY 225.0% QoQ | 107 25.9% YoY 37.2% QoQ | 19 137.5% YoY -82.2% QoQ | 73 204.2% YoY 284.2% QoQ |
| 2021 | 42 -46.2% YoY -42.5% QoQ | 34 -68.2% YoY -19.0% QoQ | 179 842.1% YoY 426.5% QoQ | 59 -19.2% YoY -67.0% QoQ |
| 2022 | 21 -50.0% YoY -64.4% QoQ | 32 -5.9% YoY 52.4% QoQ | 79 -55.9% YoY 146.9% QoQ | 18 -69.5% YoY -77.2% QoQ |
| 2023 | 53 152.4% YoY 194.4% QoQ | 79 146.9% YoY 49.1% QoQ | 36 -54.4% YoY -54.4% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of eFFECTOR Therapeutics was 4.04 per week. The last year interest of eFFECTOR Therapeutics compared to the last 5 years has changed by -20.05%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 31.3%.
There is not enough data for Tomivosertib clinical trials to provide analysis
There is not enough data for Tomivosertib clinical trials to provide correlation calculation
There is not enough data for Tomivosertib clinical trials to provide analysis
There is not enough data for eFFECTOR Therapeutics cancer treatment to provide analysis
There is not enough data for eFFECTOR Therapeutics cancer treatment to provide correlation calculation
There is not enough data for eFFECTOR Therapeutics cancer treatment to provide analysis
There is not enough data for Zotatifin clinical trial to provide analysis
There is not enough data for Zotatifin clinical trial to provide correlation calculation
There is not enough data for Zotatifin clinical trial to provide analysis
There is not enough data for eukaryotic initiation factor 4A inhibitor to provide analysis
There is not enough data for eukaryotic initiation factor 4A inhibitor to provide correlation calculation
There is not enough data for eukaryotic initiation factor 4A inhibitor to provide analysis
There is not enough data for eFFECTOR Therapeutics research collaboration with Pfizer to provide analysis
There is not enough data for eFFECTOR Therapeutics research collaboration with Pfizer to provide correlation calculation
There is not enough data for eFFECTOR Therapeutics research collaboration with Pfizer to provide analysis
There is not enough data for eFFECTOR Therapeutics jobs to provide analysis
There is not enough data for eFFECTOR Therapeutics jobs to provide correlation calculation
There is not enough data for eFFECTOR Therapeutics jobs to provide analysis
There is not enough data for eFFECTOR Therapeutics reviews to provide analysis
There is not enough data for eFFECTOR Therapeutics reviews to provide correlation calculation
There is not enough data for eFFECTOR Therapeutics reviews to provide analysis
There is not enough data for eFFECTOR Therapeutics California to provide analysis
There is not enough data for eFFECTOR Therapeutics California to provide correlation calculation
There is not enough data for eFFECTOR Therapeutics California to provide analysis
There is not enough data for eFFECTOR Therapeutics -stock -company to provide analysis
There is not enough data for eFFECTOR Therapeutics -stock -company to provide correlation calculation
There is not enough data for eFFECTOR Therapeutics -stock -company to provide analysis